Jupiter Neurosciences (JUNS) Operating Expenses (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Operating Expenses of $2.8 million for Q4 2025, up 93.8% year-over-year from $1.5 million in Q4 2024, and up 23.04% quarter-over-quarter from $2.3 million in Q3 2025.
Jupiter Neurosciences (JUNS) Operating Expenses (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Operating Expenses for 3 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses rose 93.8% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $8.9 million (up 189.85% YoY), while the FY2025 annual figure was $8.9 million, up 188.76% from the prior year.
- Operating Expenses rose to $2.8 million in Q4 2025 per JUNS's latest filing, from $2.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $2.8 million in Q4 2025 and bottomed at $493547.0 in Q3 2024.
- Historically, Operating Expenses has averaged $1.4 million across 3 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2024 — Operating Expenses slumped 65.78% — and 2025, when it jumped 365.42%.
- Jupiter Neurosciences' Operating Expenses stood at $535642.0 in 2023, then surged by 172.26% to $1.5 million in 2024, then surged by 93.8% to $2.8 million in 2025.
- Business Quant data shows JUNS's Operating Expenses at $2.8 million in Q4 2025, $2.3 million in Q3 2025, and $2.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 541.02 Mn |
| 10 | Jupiter Neurosciences | 4.53 Mn | 3.01 Mn | 21,064.00 | 2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 493,547.00 |
| Jun 30, 2024 | 557,077.00 |
| Mar 31, 2024 | 570,695.00 |
| Dec 31, 2023 | 535,642.00 |
| Sep 30, 2023 | 1.44 Mn |